Protalix BioTherapeutics Issues Letter to Stockholders : vim

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization...

Related Keywords

Carmiel , Ha Afon , Israel , United States , New York , Brazil , American , Dror Bashan , Chuck Padala , Chiesi Farmaceutici , Lotte Palace Hotel , Drug Administration , European Union , Pfizer Inc , European Medicines Agency , Protalix Biotherapeutics Inc , Exchange Commission , Prnewswire Protalix Biotherapeutics Inc , Chief Executive Officer , Protalix Stockholders , Global Rare Diseases , Chief Executive , Private Securities Litigation Reform Act , Protalix Biotherapeutics , Nc ,